Filter announcements
Loading...
Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.
Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for Notice of 32nd Annual General Meeting.
Lincoln Pharmaceuticals is informing shareholders about its upcoming Annual General Meeting and the availability of its Annual Report for FY25-26 via a web-link on their website. This communication is specifically for those who haven't registered their email addresses.
Lincoln Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026.
Lincoln Pharma has set September 11, 2026, as the Record Date for its 32nd Annual General Meeting. Shareholders holding shares by this date will be eligible for a final dividend of ₹1.80 per share (18% of face value) for FY2025-26, pending approval at the AGM on September 30, 2026. Book...
Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication regarding the 32nd Annual General Meeting of the Company to be held on Wednesday, September 30, 2026.